Nilotinib: A second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia

Title
Nilotinib: A second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia
Authors
Keywords
-
Journal
CLINICAL THERAPEUTICS
Volume 30, Issue 11, Pages 1956-1975
Publisher
Elsevier BV
Online
2008-12-25
DOI
10.1016/j.clinthera.2008.11.014

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search